Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

92 terminated/withdrawn out of 736 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

55 trials in Phase 3/4

Results Transparency

1 of 369 completed trials have results

Key Signals

134 recruiting1 with results77 terminated15 withdrawn

Enrollment Performance

Analytics

N/A

268(69.8%)

Phase 2

43(11.2%)

Phase 3

37(9.6%)

Phase 4

18(4.7%)

Phase 1

16(4.2%)

Early Phase 1

2(0.5%)

384Total

N/A(268)

Phase 2(43)

Phase 3(37)

Phase 4(18)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (736)

Showing 20 of 736 trials

NCT07528950Not ApplicableNot Yet Recruiting

Impact médico-économique de la télésurveillance Des Plaies Chroniques Avec Pixacare

Role: lead

NCT07528664Not ApplicableNot Yet Recruiting

Assessement of a Test a Financial-incentive Program for Pregnant Women and Their Smoking Partners to Reduce Smoking During Pregnancy.

Role: lead

NCT07492030Not Yet Recruiting

Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions

Role: lead

NCT07475325Not Yet Recruiting

Individual Factors Associated With Care Pathways Delays in Breast Cancer in Hauts-de-France.

Role: lead

NCT01780064Not ApplicableTerminated

Psychosocial Support to Facilitate the Return to Employment of Women With Breast Cancer

Role: collaborator

NCT02871167Not ApplicableActive Not Recruiting

Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation

Role: collaborator

NCT02553967Not ApplicableCompleted

Breast Reconstruction and Body Map : Assessment by Functional MRI (REMASCO)

Role: collaborator

NCT03265496Not ApplicableTerminated

Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation

Role: collaborator

NCT02121730Completed

Identification of Risk Factors Associated With Neoplastic Complications After Renal Transplantation in Nord-Pas de Calais , Normandy and Picardy Regions

Role: collaborator

NCT02448758Completed

Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais (CB(NPC)²)

Role: collaborator

NCT07461272Phase 4Not Yet Recruiting

Self-hangIng Patient and Hyperbaric Oxygen Therapy _ SIPHON Study

Role: lead

NCT07455422Not ApplicableNot Yet Recruiting

A Study of Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurrence and the Effect of Risk Profile Disclosure on Patient Quality of Life and Fear of Cancer

Role: collaborator

NCT07434739Not ApplicableNot Yet Recruiting

PAravertebral CaTheter Versus Epidural Analgesia in Totally Minimally Invasive Esophagectomies

Role: lead

NCT06523374Not ApplicableRecruiting

A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer

Role: collaborator

NCT07425028Not Yet Recruiting

Evaluation of an Intensified Systematic Screening for Congenital Hypothyroidism in Premature Newborns

Role: lead

NCT02281916Phase 2Completed

Safety Study of P28GST Treatment in Crohn's Disease Patients

Role: lead

NCT02164253Phase 2Completed

Focal Accumulation of Iron in Cerebral Regions in Early ALS (Amyotrophic Lateral Sclerosis) Patients

Role: lead

NCT04087590Phase 2Terminated

Impact of Inhaled PT003 on Complexity and Variability of Tidal Breathing and Oscillatory Mechanics in Stable COPD Patient